Symbol
| TIAM1
| contributors: mct - updated : 31-05-2022
|
HGNC name
| TIAM Rac1 associated GEF 1
|
HGNC id
| 11805
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --over
|  
|
in colorectal cancer, especially in metastatic cases, associated with hypomethylation of promoter region in colorectal cancer tissues | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
| prognostic marker for esophageal squamous cell carcinoma (ESCC) | |
may be a prognostic factor for the treatment of thyroid cancers | |
may be a useful biomarker for therapeutic strategy and control in hepatocellular carcinoma (HCC) treatment | Therapy target
|
System | Type | Disorder | Pubmed |
cancer | | | |
pharmacologic reversal of promoter hypomethylation may inhibit cell proliferation and migration | immunology | inflammatory | | |
activation of a TIAM1-Rac1 signaling module, is a potential novel therapeutic target against increased vascular permeability associated with inflammatory diseases | cancer | endocrine | thyroid | |
potential therapeutic target for the treatment of thyroid cancers | immunology | autoimmune | multiple sclerosis | |
TIAM1/RAC1 may be a therapeutic target in multiple sclerosis |
| | |
| mice lacking Tiam1 have simplified dendritic arbors, reduced dendritic spine density, and diminished excitatory synaptic transmission in the dentate gyrus |